MCID: KNZ001
MIFTS: 33

Kanzaki Disease malady

Genetic diseases, Rare diseases, Neuronal diseases, Metabolic diseases categories

Summaries for Kanzaki Disease

About this section


OMIM:45 Alpha-N-acetylgalactosaminidase (NAGA) deficiency is a very rare lysosomal storage disorder with atypical features. It... (609242) more...

MalaCards based summary: Kanzaki Disease, also known as adult-onset alpha-n-acetylgalactosaminidase deficiency, is related to schindler disease and schindler disease, type i, and has symptoms including hyperkeratosis, cognitive impairment and teleangiectasia of the skin. An important gene associated with Kanzaki Disease is NAGA (N-acetylgalactosaminidase, alpha-). The compound glucose have been mentioned in the context of this disorder. Affiliated tissues include skin and eye, and related mouse phenotype homeostasis/metabolism.

Aliases & Classifications for Kanzaki Disease

About this section
Sources:
45OMIM, 10diseasecard, 41NIH Rare Diseases, 20GeneTests, 47Orphanet, 22GTR, 60UMLS, 26ICD10 via Orphanet
See all sources

Kanzaki Disease, Aliases & Descriptions:

Name: Kanzaki Disease 45 10 41 20 47 22
Adult-Onset Alpha-N-Acetylgalactosaminidase Deficiency 41 47
Alpha-N-Acetylgalactosaminidase Deficiency Type 2 41 47
Schindler Disease Type 2 41 47
 
Naga Deficiency Type 2 41 47
Alpha-N-Acetylgalactosaminidase Deficiency Adult Onset 41
Schindler Disease, Type Ii 60


Classifications:



Characteristics (Orphanet epidemiological data):

47
kanzaki disease:
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Adult


External Ids:

OMIM45 609242
Orphanet47 79280
ICD10 via Orphanet26 E77.1

Related Diseases for Kanzaki Disease

About this section

Diseases related to Kanzaki Disease via text searches within MalaCards or GeneCards Suite gene sharing:

idRelated DiseaseScoreTop Affiliating Genes
1schindler disease10.4
2schindler disease, type i10.1
3angiokeratoma10.1
4primary hyperoxaluria9.9ACE, NAGA
5iga glomerulonephritis9.8ACE, NAGA
6diabetes mellitus, noninsulin-dependent9.7ACE, NAGA

Graphical network of diseases related to Kanzaki Disease:



Diseases related to kanzaki disease

Symptoms for Kanzaki Disease

About this section

Symptoms by clinical synopsis from OMIM:

609242

Clinical features from OMIM:

609242

Symptoms:

 47 (show all 14)
  • hyperkeratosis/ainhum/hyperkeratotic skin fissures
  • vascular anomalies of skin/mucosae
  • telangiectasiae of the skin
  • intellectual deficit/mental/psychomotor retardation/learning disability
  • autosomal recessive inheritance
  • coarse face
  • corneal clouding/opacity/vascularisation
  • depressed nasal bridge
  • thick lips
  • tinnitus
  • hearing loss/hypoacusia/deafness
  • cardiomegaly
  • lymphedema
  • peripheral neuropathy

HPO human phenotypes related to Kanzaki Disease:

(show all 36)
id Description Frequency HPO Source Accession
1 hyperkeratosis hallmark (90%) HP:0000962
2 cognitive impairment hallmark (90%) HP:0100543
3 teleangiectasia of the skin hallmark (90%) HP:0100585
4 thick lower lip vermilion typical (50%) HP:0000179
5 coarse facial features typical (50%) HP:0000280
6 tinnitus typical (50%) HP:0000360
7 hearing impairment typical (50%) HP:0000365
8 lymphedema typical (50%) HP:0001004
9 cardiomegaly typical (50%) HP:0001640
10 depressed nasal bridge typical (50%) HP:0005280
11 opacification of the corneal stroma typical (50%) HP:0007759
12 peripheral neuropathy typical (50%) HP:0009830
13 autosomal recessive inheritance HP:0000007
14 thick lower lip vermilion HP:0000179
15 lip telangiectasia HP:0000214
16 coarse facial features HP:0000280
17 sensorineural hearing impairment HP:0000407
18 abnormality of the eye HP:0000478
19 dry skin HP:0000958
20 hyperkeratosis HP:0000962
21 lymphedema HP:0001004
22 angiokeratoma corporis diffusum HP:0001071
23 intellectual disability, mild HP:0001256
24 cerebral atrophy HP:0002059
25 vertigo HP:0002321
26 distal muscle weakness HP:0002460
27 distal sensory impairment HP:0002936
28 aminoaciduria HP:0003355
29 distal sensory impairment of all modalities HP:0003409
30 increased urinary o-linked sialopeptides HP:0003461
31 peripheral axonal neuropathy HP:0003477
32 adult onset HP:0003581
33 depressed nasal bridge HP:0005280
34 white mater abnormalities in the posterior periventricular region HP:0006812
35 telangiectasia of the oral mucosa HP:0007428
36 cognitive impairment HP:0100543

Drugs & Therapeutics for Kanzaki Disease

About this section

Drug clinical trials:

Search ClinicalTrials for Kanzaki Disease

Search NIH Clinical Center for Kanzaki Disease

Genetic Tests for Kanzaki Disease

About this section

Genetic tests related to Kanzaki Disease:

id Genetic test Affiliating Genes
1 Kanzaki Disease20 22 NAGA

Anatomical Context for Kanzaki Disease

About this section

MalaCards organs/tissues related to Kanzaki Disease:

31
Skin, Eye

Animal Models for Kanzaki Disease or affiliated genes

About this section

MGI Mouse Phenotypes related to Kanzaki Disease:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053769.1ACE, NAGA

Publications for Kanzaki Disease

About this section

Articles related to Kanzaki Disease:

idTitleAuthorsYear
1
The 1.9 A structure of human alpha-N-acetylgalactosaminidase: the molecular basis of Schindler and Kanzaki diseases. (19683538)
2009
2
Three dimensional structural studies of alpha-N-acetylgalactosaminidase (alpha-NAGA) in alpha-NAGA deficiency (Kanzaki disease): different gene mutations cause peculiar structural changes in alpha-NAGAs resulting in different substrate specificities and clinical phenotypes. (15619430)
2005
3
Structural and immunocytochemical studies on alpha-N-acetylgalactosaminidase deficiency (Schindler/Kanzaki disease). (14685826)
2004
4
Neurologic manifestations of Kanzaki disease. (15136691)
2004
5
Schindler disease/Kanzaki disease [alpha-N-acetylgalactosaminidase deficiency]]. (9645085)
1998
6
Histopathologic and ultrastructural studies of angiokeratoma corporis diffusum in Kanzaki disease. (7897017)
1995
7
Schindler disease/Kanzaki disease]. (8577046)
1995
8
Isolation and characterization of major urinary amino acid O-glycosides and a dipeptide O-glycoside from a new lysosomal storage disorder (Kanzaki disease). Excessive excretion of serine- and threonine-linked glycan in the patient urine. (2104850)
1990

Variations for Kanzaki Disease

About this section

UniProtKB/Swiss-Prot genetic disease variations for Kanzaki Disease:

62
id Symbol AA change Variation ID SNP ID
1NAGAp.Arg329TrpVAR_000498
2NAGAp.Arg329GlnVAR_022525rs121434533

Clinvar genetic disease variations for Kanzaki Disease:

6
id Gene Variation Type Significance SNP ID Assembly Location
1NAGANM_000262.2(NAGA): c.985C> T (p.Arg329Trp)single nucleotide variantPathogenicrs121434530GRCh37Chr 22, 42457044: 42457044
2NAGANM_000262.2(NAGA): c.577G> T (p.Glu193Ter)single nucleotide variantPathogenicrs121434531GRCh37Chr 22, 42462734: 42462734
3NAGANM_000262.2(NAGA): c.986G> A (p.Arg329Gln)single nucleotide variantPathogenicrs121434533GRCh37Chr 22, 42457043: 42457043

Expression for genes affiliated with Kanzaki Disease

About this section
Search GEO for disease gene expression data for Kanzaki Disease.

Pathways for genes affiliated with Kanzaki Disease

About this section

Compounds for genes affiliated with Kanzaki Disease

About this section
Sources:
43Novoseek
See all sources

Compounds related to Kanzaki Disease according to GeneCards Suite gene sharing:

idCompoundScoreTop Affiliating Genes
1glucose439.1ACE, NAGA

GO Terms for genes affiliated with Kanzaki Disease

About this section

Products for genes affiliated with Kanzaki Disease

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Kanzaki Disease

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet